MAPK9 and neoplasm: Evidence from the MMTV- polyoma middle T (PymT) transgenic model also showed a tumor suppressive function for JNK as MMTV-PymT; JNK2-/- displayed shortened tumor latency and increased tumor multiplicity when compared to MMTV-PymT control mice [27].